Modern treatment for nasopharyngeal carcinoma: current status and prospects. Comparison of long-term survival and toxicity of cisplatin delivered weekly versus every three weeks concurrently with intensity-modulated radiotherapy in nasopharyngeal carcinoma. Mai HQ. Emerging treatment options for nasopharyngeal carcinoma. Drug Des. Mann JR. Caring for survivors of childhood cancers: the size of the problem. Targeted therapy: a new hope for thyroid carcinomas. Shong YK. Current status and future perspectives in differentiated thyroid cancer.
Seoul ; 29 — Adopting network pharmacology for cancer drug discovery. Drug Discov. The war on cancer: are we winning? Tumour Biol. The war on cancer: lessons from the war on terror. Non-Darwinian dynamics in therapy-induced cancer drug resistance. Huang S. Non-genetic heterogeneity—a mutation-independent driving force for the somatic evolution of tumours. Tumor progression: chance and necessity in Darwinian and Lamarckian somatic mutationless evolution. Liao DJ. Just like the rest of evolution in Mother Nature, the evolution of cancers may be driven by natural selection, and not by haphazard mutations.
Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptions.
Actions for selected content:
The beneficial effects of bacterial infections on host resistance to cancer. End results in cases. A study and abstracts of reports in the world medical literature — and personal communication. Cancer Res. Uber den Einfluss welche heftigere Erysipeln zuweilig auf organisierte Neubildungenausuben. Aus der sitzung der medicinischen section.
Fever and cancer in perspective.
- Posts navigation.
- My New Friends At the Zoo (Read With Me, Pops).
- Bluegrass Bluesman: A Memoir (Music in American Life);
- So You Want to be a Sprinter.
- No Way Baby! Exploring, Understanding and Defending the Decision NOT to Have Children!
Cancer Immunol. Die Heilwirkung des Erysipels auf Geschwulste. Dr William Coley and tumour regression: a place in history or in the future. McLaren JR. Coley toxins—the first century.
Starnes CO. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinoma. Tumor Pharmacother. Bacteria and cancer—antagonisms and benefits. Cancer Surv.
Dewhirst MW. Temperature matters! And why it should matter to tumor immunologists. Fever in cancer treatment: Coley's therapy and epidemiologic observations. Glob Adv. Health Med. Bacterial pyrogens: beneficial effects on cancer patients. Immunity over inability: the spontaneous regression of cancer. Glover DW. Spontaneous regression: a hidden treasure buried in time. Spontaneous regression of cancer. Stenzinger W. Fever, cancer incidence and spontaneous remissions. Milan G. Fluctuations in the growth energy of malignant tumors in man, with especial reference to spontaneous recession.
Acute infections as a means of cancer prevention: opposing effects to chronic infections?
Cancer Detect. Whole body hyperthermia as an anticancer agent. CA Cancer J. Martin E. Chemotherapy of malignant neoplastic diseases. Complex landscapes of somatic rearrangement in human breast cancer genomes.
Badini M. The role of innate immunity in spontaneous regression of cancer. Indian J. Fever therapy revisited. Stam HJ. The spontaneous regression of cancer. A review of cases from to Acta Oncol. Haferkamp B.
Record-breaker Dawid Malan is in captain Eoin Morgan's bad books over his failure to run
Febrile infections and malignant melanoma: results of a case-control study. Melanoma Res. Cegolon L. Endotoxin and cancer chemo-prevention. Cancer Epidemiol. Toward general prophylactic cancer vaccination. Hobohm U. Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy.
Common infections in the history of cancer patients and controls. An anniversary for cancer chemotherapy. Newman DJ. New horizons for old drugs and drug leads. Natural products: a continuing source of novel drug leads. Moll U. Targeting tumour-supportive cellular machineries in anticancer drug development. Cell Cycle.
Western Fiction Review: Morgan Kane: El Gringo and El Gringo's Revenge
Cancer: beyond speciation. Kiessling R. Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation. Cell Death Dis. Apetoh L.
morgan kane tekst
Enhancing the anticancer effects of 5-fluorouracil: current challenges and future perspectives. NCI's provocative questions on cancer: some answers to ignite discussion. Johnston PG. Cancer drug resistance: an evolving paradigm. Hurov JB. Targeting metabolic changes in cancer: novel therapeutic approaches. Dash PR. First steps in experimental cancer evolution. Chabner B.